Kathleen E O'Neill1, Suneeta Senapati2, Ivy Maina3, Clarisa Gracia2, Anuja Dokras2. 1. Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Pennsylvania, Pennsylvania, PA, USA. kathleen.o'neill2@uphs.upenn.edu. 2. Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Pennsylvania, Pennsylvania, PA, USA. 3. School of Medecine, University of Pennsylvania, 3701 Market Street, Suite 800, Philadelphia, PA, 19104, USA.
Abstract
PURPOSE: The purpose of this study was to compare rates of ovarian hyperstimulation syndrome (OHSS) after using gonadotropin-releasing hormone agonists (GnRHa) alone and GnRHa in combination with low-dose human chorionic gonadotropin (hCG, dual trigger) for final oocyte maturation in women undergoing controlled ovarian hyperstimulation (COH). METHODS: A retrospective cohort study was conducted at an academic center. Study population included 108 women who received GnRHa trigger and 66 women who received dual trigger (GnRHa + low-dose [1000 IU] hCG trigger). The main outcome measure was OHSS. Secondary outcomes included total oocyte yield and oocyte maturity. RESULTS: The incidence of early OHSS was significantly higher after dual trigger than GnRHa trigger (8.6 vs 0 %). Moreover, four of the six patients that developed OHSS developed severe OHSS. Logistic modeling revealed that the combination of age, BMI, baseline AFC, and E2 >4000 pg/mL was predictive of OHSS with an area under the receiver operating characteristic curve of 0.84 and was superior to each factor alone. Adjusted analyses revealed that dual trigger was associated with a higher number of total oocytes (adjusted OR 1.27; 95 % confidence interval, 1.18, 1.38) and percentage of mature oocytes (AOR 1.10; 95 % confidence interval, 1.03, 1.17) obtained compared to GnRHa trigger alone. CONCLUSIONS: Dual trigger for final oocyte maturation using GnRHa and low-dose hCG is associated with a significantly increased risk of severe OHSS compared to GnRH alone. However, dual trigger may be associated with a modest increase in oocyte yield, both in terms of number and maturity.
PURPOSE: The purpose of this study was to compare rates of ovarian hyperstimulation syndrome (OHSS) after using gonadotropin-releasing hormone agonists (GnRHa) alone and GnRHa in combination with low-dose human chorionic gonadotropin (hCG, dual trigger) for final oocyte maturation in women undergoing controlled ovarian hyperstimulation (COH). METHODS: A retrospective cohort study was conducted at an academic center. Study population included 108 women who received GnRHa trigger and 66 women who received dual trigger (GnRHa + low-dose [1000 IU] hCG trigger). The main outcome measure was OHSS. Secondary outcomes included total oocyte yield and oocyte maturity. RESULTS: The incidence of early OHSS was significantly higher after dual trigger than GnRHa trigger (8.6 vs 0 %). Moreover, four of the six patients that developed OHSS developed severe OHSS. Logistic modeling revealed that the combination of age, BMI, baseline AFC, and E2 >4000 pg/mL was predictive of OHSS with an area under the receiver operating characteristic curve of 0.84 and was superior to each factor alone. Adjusted analyses revealed that dual trigger was associated with a higher number of total oocytes (adjusted OR 1.27; 95 % confidence interval, 1.18, 1.38) and percentage of mature oocytes (AOR 1.10; 95 % confidence interval, 1.03, 1.17) obtained compared to GnRHa trigger alone. CONCLUSIONS: Dual trigger for final oocyte maturation using GnRHa and low-dose hCG is associated with a significantly increased risk of severe OHSS compared to GnRH alone. However, dual trigger may be associated with a modest increase in oocyte yield, both in terms of number and maturity.
Authors: M B Zelinski-Wooten; J S Hutchison; I Trinchard-Lugan; D L Hess; D P Wolf; R L Stouffer Journal: Hum Reprod Date: 1997-09 Impact factor: 6.918
Authors: María Cerrillo; Alberto Pacheco; Sara Rodríguez; Raúl Gómez; Francisco Delgado; Antonio Pellicer; Juan A Garcia-Velasco Journal: Fertil Steril Date: 2011-01-26 Impact factor: 7.329
Authors: R Agrawal; S L Tan; S Wild; P Sladkevicius; L Engmann; N Payne; J Bekir; S Campbell; G Conway; H Jacobs Journal: Fertil Steril Date: 1999-02 Impact factor: 7.329
Authors: Condesmar M de Oliveira; Carlos A M de Oliveira; Larissa L Fonseca; Kelly R R de Souza; Moacir R M Radaelli Journal: JBRA Assist Reprod Date: 2021-04-27
Authors: L L Engmann; B S Maslow; L A Kaye; D W Griffin; A J DiLuigi; D W Schmidt; D R Grow; J C Nulsen; C A Benadiva Journal: J Ovarian Res Date: 2019-01-26 Impact factor: 4.234